Posts in Biosector

by Stefan Sandström
June 16, 2025

What AstraZeneca’s AI Strategy in China Means for Global Pharma — and Why Japan is a Better Play

  Just now, AstraZeneca is making headlines with a $5.3 billion AI research partnership with China’s […]
0
read more
Biosector is engaged in the Japanese pharmaceutical market.
by Stefan Sandström
November 23, 2023

Biosector, Pelago and SwedenBIO Eyeing Expansion at BioJapan 2023

Embracing Opportunities in Japan With great excitement and a sense of humble pride, I share our […]
0
read more